Compatibility of Insulin Lispro, Aspart, and Glulisine with the Solo™ MicroPump, a Novel Miniature Insulin Pump

Diabetes mellitus patients require administration of varying amounts of insulin throughout the day to control their blood glucose levels. In recent years, ambulatory portable continuous subcutaneous insulin infusion (CSII) devices, known as “insulin pumps,” have emerged as a superior alternative to multiple daily injections for type 1
diabetes patients.
This study compared the stability of commercially available, rapid-acting insulin in the novel tubeless, skin-adhering Solo™ insulin pump over 6 days at extreme environmental conditions.